Dalal MR - Search Results

1

Achievement of Target A1C <7.0% (<53 mmol/mol) by U.S. Type 2 Diabetes Patients Treated With Basal Insulin in Both Randomized Controlled Trials and Clinical Practice.

Blonde L, Brunton SA, Chava P, Zhou R, Meyers J, Davis KL, Dalal MR, DiGenio A. Blonde L, et al. Among authors: dalal mr. Diabetes Spectr. 2019 May;32(2):93-103. doi: 10.2337/ds17-0082. Diabetes Spectr. 2019. PMID: 31168279 Free PMC article.

2

Are patients on basal insulin attaining glycemic targets? Characteristics and goal achievement of patients with type 2 diabetes mellitus treated with basal insulin and physician-perceived barriers to achieving glycemic targets.

Dalal MR, Grabner M, Bonine N, Stephenson JJ, DiGenio A, Bieszk N. Dalal MR, et al. Diabetes Res Clin Pract. 2016 Nov;121:17-26. doi: 10.1016/j.diabres.2016.08.004. Epub 2016 Aug 24. Diabetes Res Clin Pract. 2016. PMID: 27616634 Free article.

3

Adding Rapid-Acting Insulin or GLP-1 Receptor Agonist to Basal Insulin: Outcomes in a Community Setting.

Dalal MR, Xie L, Baser O, DiGenio A. Dalal MR, et al. Endocr Pract. 2015 Jan;21(1):68-76. doi: 10.4158/EP14290.OR. Endocr Pract. 2015. PMID: 25148821

4

Prandial insulin versus glucagon-like peptide-1 added to basal insulin: comparative effectiveness in the community practice setting.

Digenio A, Karve S, Candrilli SD, Dalal M. Digenio A, et al. Postgrad Med. 2014 Oct;126(6):49-59. doi: 10.3810/pgm.2014.10.2820. Postgrad Med. 2014. PMID: 25414934

5

Type 2 diabetes mellitus treatment patterns in U.S. nursing home residents.

Zarowitz B, Allen C, O'Shea T, Dalal MR, Haumschild M, DiGenio A. Zarowitz B, et al. Among authors: dalal mr. Postgrad Med. 2015 Jun;127(5):429-37. doi: 10.1080/00325481.2015.1035621. Epub 2015 Apr 7. Postgrad Med. 2015. PMID: 25850712

6

Achieve control: a pragmatic clinical trial of insulin glargine 300 U/mL versus other basal insulins in insulin-naïve patients with type 2 diabetes.

Oster G, Sullivan SD, Dalal MR, Kazemi MR, Rojeski M, Wysham CH, Sung J, Johnstone B, Cali AM, Wei LJ, Traylor L, Anhalt H, Hull M, Van Vleet J, Meneghini LF. Oster G, et al. Among authors: dalal mr. Postgrad Med. 2016 Nov;128(8):731-739. doi: 10.1080/00325481.2016.1241663. Epub 2016 Oct 24. Postgrad Med. 2016. PMID: 27690710 Clinical Trial.

7

Efficacy and Safety of Insulin Glargine 300 U/mL Versus Insulin Glargine 100 U/mL in High-Risk and Low-Risk Patients with Type 2 Diabetes Stratified Using Common Clinical Performance Measures.

Lingvay I, Chao J, Dalal MR, Meneghini LF. Lingvay I, et al. Among authors: dalal mr. Diabetes Technol Ther. 2017 May;19(5):315-322. doi: 10.1089/dia.2016.0454. Epub 2017 May 3. Diabetes Technol Ther. 2017. PMID: 28467113 Free PMC article. Clinical Trial.

8

Hypoglycemia After Initiation of Basal Insulin in Patients with Type 2 Diabetes in the United States: Implications for Treatment Discontinuation and Healthcare Costs and Utilization.

Dalal MR, Kazemi M, Ye F, Xie L. Dalal MR, et al. Adv Ther. 2017 Sep;34(9):2083-2092. doi: 10.1007/s12325-017-0592-x. Epub 2017 Aug 4. Adv Ther. 2017. PMID: 28779282 Free PMC article.

9

Hypoglycemia in patients with type 2 diabetes newly initiated on basal insulin in the US in a community setting: impact on treatment discontinuation and hospitalization.

Dalal MR, Kazemi MR, Ye F. Dalal MR, et al. Curr Med Res Opin. 2017 Feb;33(2):209-214. doi: 10.1080/03007995.2016.1248911. Epub 2016 Nov 4. Curr Med Res Opin. 2017. PMID: 27737571

10

Real-world evaluation of the effects of counseling and education in diabetes management.

Dalal MR, Robinson SB, Sullivan SD. Dalal MR, et al. Diabetes Spectr. 2014 Nov;27(4):235-43. doi: 10.2337/diaspect.27.4.235. Diabetes Spectr. 2014. PMID: 25647045 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

36 results

Search Page